App may let some hypertension patients skip doctor visits

NCT ID NCT06524180

Recruiting now Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a telemedicine system (HealthCap app) can keep blood pressure under control as well as regular face-to-face doctor visits in people with stable hypertension. About 364 participants will either use the app for remote monitoring and automatic medication refills, or continue standard in-person checkups every 16-18 weeks. The main goal is to see if blood pressure readings are similar between the two groups after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: telemedicine mobile app and platform
What this could lead to: If successful, this could show that telemedicine is a safe and cost-effective alternative to in-person doctor visits for managing stable hypertension.
What could go wrong: This is a relatively small trial (364 participants) and only includes people whose blood pressure is already well-controlled. The results may not apply to those with uncontrolled hypertension or other health issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION

Contacts and locations

Locations

HKW and NTEC GOPC
RECRUITING

Hong Kong, Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.